AIFM2 and lung carcinoma: Similarly, NRF2 transcriptionally activates ferroptosis suppressor protein 1 (FSP1), which mediates ferroptosis- and radiation-resistance in KEAP1-mutated lung cancer cells (Koppula et al., 2022).